Tourniquet Use in Hallux Valgus Surgery

Clinique Saint Jean, France44 enrolled

Overview

Prospective, single-center, randomized interventional clinical trial of tourniquet use in hallux valgus surgery. Patients will be their own controls.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Hallux Valgus

Interventions

tourniquetOTHER

peroperation tourniquet

No tourniquetOTHER

no tourniquet during surgery

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients over 18 who has been informed and has signed the consent form * Patient to be operated on for bilateral hallux valgus with no difference in the procedure performed between the 2 feet, the deformity must not differ by more than 10° (angle M1P1) between the 2 sides. * Surgery planned on the same day for both feet Exclusion Criteria: * Arthritic hallux valgus requiring arthrodesis * Inflammatory pathology (rheumatoid arthritis, etc.)

Locations (1)

Clinique St Jean Sud de France

Saint-Jean-de-Védas, France

RECRUITING

Outcomes

Primary Outcomes

Average pain in the first week after surgery

Comparison between the 2 groups of the average VAS over the first week following surgery, from 0 to 100 points, 0 being the value where the patient has no pain and 100 the maximum pain value.

Time frame: first week after surgery

Secondary Outcomes

Edema

Measurement of foot edema at D10 during the consultation, taking the difference in cm between the postoperative measurement and the preoperative measurement.

Time frame: Day 10 after surgery

Complications

Occurrence of complications specific to tourniquet use as a percentage in each arm.

Time frame: first week after surgery

Central Contacts

Cecile Spirito

CONTACT

0033467413400 cecile.spirito@capsante.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.